Fernando Dario Cuello Carrion

Dr. Fernando Dario Cuello Carrion

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
FCFernando Dario Cuello Carrion
Fernando Dario Cuello Carrion
JSJorge E. Shortrede
Jorge E. Shortrede
Daiana Alvarez-OlmedoDaiana Alvarez-Olmedo
Daiana Alvarez-Olmedo
NGNiubys de los Milagros Cayado Gutiérrez
Niubys de los Milagros Cayado Gutiérrez
GCGisela N. Castro
Gisela N. Castro
DCDaniel R. Ciocca
Daniel R. Ciocca

15 November 2011 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
DCDaniel R. Ciocca
Daniel R. Ciocca
FCFernando Dario Cuello Carrion
Fernando Dario Cuello Carrion
ANAnthony L. Natoli
Anthony L. Natoli
CRChristina Restall
Christina Restall
RARobin Anderson
Robin Anderson

11 February 2025 in Biology
Verified
Journal Article
Open access
PDF file
SNSilvina B Nadin
Silvina B Nadin
FCFernando Dario Cuello Carrion
Fernando Dario Cuello Carrion
NGNiubys de los Milagros Cayado Gutiérrez
Niubys de los Milagros Cayado Gutiérrez
MFMariel A. Fanelli
Mariel A. Fanelli
The Wnt/β-catenin pathway takes part in important cellular processes in tumor cells, such as gene expression, adhesion, and survival. The canonical pathway is activated in several tumors, and β-catenin is its major effector. The union of Wnt to the co-receptor complex causes the inhibition of GSK3β activity, thus preventing the phosphorylation and degradation of β-catenin, which accumulates in the cytoplasm, to subsequently be transported to the nucleus to associate with transcription factors. The relationship between Wnt/β-catenin and DNA damage/repair mechanisms has been a focus for the last few years. Studying the Wnt/β-catenin network interactions with DNA damage/repair proteins has become a successful research field. This review provides an overview of the participation of Wnt/β-catenin in DNA damage/repair mechanisms and their future implications as targets for cancer therapy.

1 September 2013 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
FCFernando Dario Cuello Carrion
Fernando Dario Cuello Carrion
NGNiubys de los Milagros Cayado Gutiérrez
Niubys de los Milagros Cayado Gutiérrez
ANAnthony L. Natoli
Anthony L. Natoli
CRChristina Restall
Christina Restall
RARobin Anderson
Robin Anderson
DCDaniel R. Ciocca
Daniel R. Ciocca
In a recent study, we have shown that in mammary tumors from mice lacking the Cav-1 gene, there are alterations in specific heat shock proteins as well as in tumor development. With this in mind, we have now investigated other proteins in the same mammary mouse tumor model (Her-2/neu expressing mammary tumors from Cav-1 wild type and Cav-1 null mice), to further comprehend the complex tumor-stroma mechanisms involved in regulating stress responses during tumor development. In this tumor model the cancer cells always lacked of Cav-1, so the KO influenced the Cav-1 in the stroma. By immunohistochemistry, we have found a striking co-expression of β-catenin and Her-2/neu in the tumor cells. The absence of Cav-1 in the tumor stroma had no effect on expression or localization of β-catenin and Her-2/neu. Both proteins appeared co-localized at the cell surface during tumor development and progression. Since Her-2/neu activation induces MTA1, we next evaluated MTA1 in the mouse tumors. Although this protein was found in numerous nuclei, the absence of Cav-1 did not alter its expression level. In contrast, significantly more PTEN protein was noted in the tumors lacking Cav-1 in the stroma, with the protein localized mainly in the nuclei. P-Akt levels were relatively low in tumors from both Cav-1 WT and Cav-1 KO mice. There was also an increase in nuclear NHERF1 expression levels in the tumors arising from Cav-1 KO mice. The data obtained in the MMTV-neu model are consistent with a role for Cav-1 in adjacent breast cancer stromal cells in modulating the expression and localization of important proteins implicated in tumor cell behavior.